Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Neutral by HC Wainwright with a price target of $6.00

Analyst Ratings For Acorda Therapeutics Inc (NASDAQ:ACOR)

Story continues below

Today, Acorda Therapeutics Inc (NASDAQ:ACOR) stock was downgraded by HC Wainwright from Buy to Neutral with a price target of $6.00.

There are 7 Hold Ratings, 2 Sell Ratings, 1 Buy Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on Acorda Therapeutics Inc (NASDAQ:ACOR) is Hold with a consensus target price of $13.2222 per share, a potential 384.33% upside.

Some recent analyst ratings include

  • 8/14/2019-Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Neutral by HC Wainwright with a price target of $6.00
  • 3/19/2019-Acorda Therapeutics Inc (NASDAQ:ACOR) had its Hold rating reiterated by Oppenheimer
  • 1/7/2019-Acorda Therapeutics Inc (NASDAQ:ACOR) had its Buy rating reiterated by Cowen with a $30.00 price target
  • On 2/22/2019 Lauren M Sabella, Insider, sold 761 with an average share price of $13.18 per share and the total transaction amounting to $10,029.98.
  • On 1/30/2019 Scopia Capital Management Lp, Major Shareholder, sold 7,000 with an average share price of $16.01 per share and the total transaction amounting to $112,070.00.
  • On 1/25/2019 Scopia Capital Management Lp, Major Shareholder, sold 11,001 with an average share price of $16.02 per share and the total transaction amounting to $176,236.02.
  • On 1/23/2019 Scopia Capital Management Lp, Major Shareholder, sold 97,843 with an average share price of $16.01 per share and the total transaction amounting to $1,566,466.43.
  • On 1/17/2019 Scopia Capital Management Lp, Major Shareholder, sold 100,000 with an average share price of $16.86 per share and the total transaction amounting to $1,686,000.00.
  • On 1/15/2019 Scopia Capital Management Lp, Major Shareholder, sold 1,700 with an average share price of $16.60 per share and the total transaction amounting to $28,220.00.
  • On 1/10/2019 Scopia Capital Management Lp, Major Shareholder, sold 162,491 with an average share price of $17.18 per share and the total transaction amounting to $2,791,595.38.

Recent Trading Activity for Acorda Therapeutics Inc (NASDAQ:ACOR)
Shares of Acorda Therapeutics Inc closed the previous trading session at 2.73 −0.100 3.53% with 2.61 shares trading hands.

An ad to help with our costs